subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now
Picture: SUPPLIED
Picture: SUPPLIED

Ascendis Health continues to tackle its debt. The firm recently inked a deal with Austell to sell its pharma unit and also plans to raise over R100m via a rights offer. Business Day TV caught up with Ascendis Health's CFO and interim CEO, Cheryl-Jane Kujenga, for more detail on the recovery plan.

Or listen to full audio

Subscribe for free episodes: iono.fm | Apple Podcasts | Spotify | Pocket Casts | Player.fm

Companies in this Story

subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.